FEDERATED HERMES, INC. - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 199 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.4%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$7,549,379
+1.1%
1,385,207
+24.5%
0.02%
+5.3%
Q2 2023$7,464,788
-28.1%
1,112,487
-5.4%
0.02%
-26.9%
Q1 2023$10,384,574
-3.4%
1,176,056
-16.4%
0.03%
-13.3%
Q4 2022$10,750,901
+7.7%
1,407,186
+0.4%
0.03%
+3.4%
Q3 2022$9,978,000
-11.7%
1,401,339
+0.3%
0.03%
-6.5%
Q2 2022$11,306,000
+46.5%
1,397,533
+151.3%
0.03%
+82.4%
Q1 2022$7,720,000
+356.5%
556,199
+1224.3%
0.02%
+466.7%
Q1 2021$1,691,000
-52.4%
42,000
-30.1%
0.00%
-57.1%
Q4 2020$3,553,000
+74.0%
60,088
+43.1%
0.01%
+40.0%
Q3 2020$2,042,000
+0.5%
42,0000.0%0.01%0.0%
Q2 2020$2,032,000
+29.9%
42,000
-25.4%
0.01%0.0%
Q1 2020$1,564,000
+10.7%
56,296
+19.2%
0.01%
+66.7%
Q4 2019$1,413,000
+8.9%
47,235
+12.5%
0.00%0.0%
Q3 2019$1,298,000
-64.2%
42,000
-44.0%
0.00%
-66.7%
Q2 2019$3,623,00075,0000.01%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2020
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders